The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Open accessAbstract
BACKGROUND: The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS: We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS: After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS: In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prediabetes is linked with increased risks of major manifestations of vascular disease, but it remains unclear whether the elevated disease risks depend on development of clinical diabetes.84,85”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“A recent individual-level evidence from prospective studies suggests that fasting hyperglycaemia (figure 3), postload glucose, and A1c are all robust predictors of vascular mortality86,88,89 and, according to multivariable adjusted analyses, these associations are independent of vascular risk factors, such as obesity, blood pressure, triglyceride and lipoproteins.84,85,87”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“The study found that a 50-year-old with T2DM died, on average, 6 years earlier than an individual without T2DM, with about 40% of the difference in survival attributable to excess non-vascular deaths.95”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“Aside from CV death, results from the Emerging Risk Factors Collaboration, including 820 900 people, demonstrate that T2DM is independently associated with increased risk of death from several cancers (i.e.liver, pancreas, ovary, colorectum, lung, bladder, and breast), renal and liver disease, pneumonia and other infectious diseases, mental and nervous system disorders, non-hepatic digestive dis”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“These are consistent with downward secular trends in cardiovascular disease and improvements in mortality and are in line with previously reported estimates of the reduction in life expectancy due to diabetes [23].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Self-citationMortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,010
Schernthaner, G., Durán-Garcia, S., Hanefeld, M., Langslet, G., NISKANEN, L. K., Östgren, C. J., Malvolti, E., & Hardy, E. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12461 · Cited by 64
Matsumoto, S., Shimabukuro, M., Fukuda, D., Soeki, T., Yamakawa, K., Masuzaki, H., & Sata, M. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-30 · Cited by 66
Penno, G., Solini, A., Bonora, E., Orsi, E., Fondelli, C., Zerbini, G., Trevisan, R., Vedovato, M., Cavalot, F. L., Laviola, L., et al. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1133-z · Cited by 64
Mohammedi, K., Bellili-Muñoz, N., Marklund, S. L., Driss, F., Le Nagard, H., Patente, T. A., Fumeron, F., Roussel, R., Hadjadj, S., Marre, M., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0163-2 · Cited by 63
Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus
Brownrigg, J. R. W., Griffin, M., Hughes, C., Jones, K. G., Patel, N., Thompson, M. M., & Hinchliffe, R. J. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.052 · Cited by 63
Sitagliptin and the risk of hospitalization for heart failure: A population-based study
Wang, K.-L., Liu, C., Chao, T., Huang, C.-M., Wu, C., Chen, S., Yeh, C., Chen, T., Lin, S., & Chiang, C. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.038 · Cited by 63
Noto, H., Tsujimoto, T., & Noda, M. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00183.x · Cited by 63
High serum glucose levels are associated with a higher perceived age
On behalf of the Leiden Longevity Study Group, Noordam, R., Gunn, D. A., Tomlin, C. C., Maier, A. B., Mooijaart, S. P., Slagboom, P. E., Westendorp, R. G. J., de Craen, A. J. M., & van Heemst, D. (2011) · AGE · doi:10.1007/s11357-011-9339-9 · Cited by 63
Mortality and Its Determinants in People With Psychotic Disorder
Suvisaari, J., Partti, K., Perälä, J., Viertiö, S., Saarni, S. E., Lönnqvist, J. K., Saarni, S. I., & Härkänen, T. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31827ad512 · Cited by 66
NAFLD/NASH in patients with type 2 diabetes and related treatment options
Radaelli, M. G., Martucci, F., Perra, S., Accornero, S., Castoldi, G., Lattuada, G., Manzoni, G., & Perseghin, G. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0799-3 · Cited by 63
Tripathy, J. P. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s157376 · Cited by 62
Carrillo-Larco, R. M., Barengo, N. C., Albitres‐Flores, L., & Bernabé‐Ortiz, A. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3139 · Cited by 63
Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events
Yang, Y., Peng, N., Chen, G., Wan, Q., Li, Y., Wang, G., Qin, Y., Luo, Z., Tang, X., Huo, Y., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01447-2 · Cited by 74
Strategies for preventing type 2 diabetes: an update for clinicians
Khavandi, K., Amer, H., Ibrahim, B., & Brownrigg, J. R. W. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313494986 · Cited by 62
Association of Glycation Gap With Mortality and Vascular Complications in Diabetes
Nayak, A., Nevill, A. M., Bassett, P., & Singh, B. M. (2013) · Diabetes Care · doi:10.2337/dc12-1040 · Cited by 61
de Jager, S. C. A., Bongaerts, B. W. C., Weber, M., Kraaijeveld, A. O., Rousch, M., Dimmeler, S., van Dieijen‐Visser, M. P., Cleutjens, K. B. J. M., Nelemans, P. J., van Berkel, T. J. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045804 · Cited by 62
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
Hemmati, M., Zohoori, E., Mehrpour, O., Karamian, M., Asghari, S., Zarban, A., & Nasouti, R. (2015) · EXCLI journal · doi:10.17179/excli2015-232 · Cited by 62
Paulsen, J., Askim, Å., Mohus, R. M., Mehl, A., DeWan, A. T., Solligård, E., Damås, J. K., & Åsvold, B. O. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx091 · Cited by 62
DeJesus, R. S., Breitkopf, C. R., Rutten, L. J. F., Jacobson, D. J., Wilson, P. M., & Sauver, J. L. S. (2016) · Population Health Management · doi:10.1089/pop.2016.0067 · Cited by 61
Yacovo, S. D., García‐Vidal, C., Viasus, D., Adamuz, J., Oriol, I., Gili, F., Vilarrasa, N., García-Somoza, D., Dorca, J., & Carratalà, J. (2012) · Medicine · doi:10.1097/md.0b013e31827f602a · Cited by 64
Laugesen, E., Høyem, P., Stausbøl‐Grøn, B., Mikkelsen, A., Thrysøe, S. A., Erlandsen, M., Christiansen, J. S., Knudsen, S. T., Hansen, K. W., Kim, W. Y., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0942 · Cited by 61
Sleep and Multisystem Biological Risk: A Population-Based Study
Carroll, J., Irwin, M. R., Merkin, S. S., & Seeman, T. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118467 · Cited by 61
Hirakawa, Y., Ninomiya, T., Mukai, N., Doi, Y., Hata, J., Fukuhara, M., Iwase, M., Kitazono, T., & Kiyohara, Y. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws178 · Cited by 61
Low Hemoglobin A1c in Nondiabetic Adults
Aggarwal, V., Schneider, A. L. C., & Selvin, E. (2012) · Diabetes Care · doi:10.2337/dc11-2531 · Cited by 60
Causes of Death Associated With Prolonged TV Viewing
Keadle, S. K., Moore, S. C., Sampson, J. N., Xiao, Q., Albanes, D., & Matthews, C. E. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.05.023 · Cited by 62
Saulnier, P., Gand, E., Velho, G., Mohammedi, K., Zaoui, P., Fraty, M., Halimi, J., Roussel, R., Ragot, S., & Hadjadj, S. (2016) · Diabetes Care · doi:10.2337/dc16-1571 · Cited by 61
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects
Visca, D., Pignatti, P., Spanevello, A., Lucini, E., & Rocca, E. L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.008 · Cited by 63
The Role of Glucocorticoids in the Management of COVID-19
Alexaki, V. I., & Henneicke, H. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1300-2550 · Cited by 61
The biological and pharmacological connections between diabetes and various types of cancer
Wang, X., & Ding, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153641 · Cited by 60
Boehme, M. W. J., Buechele, G., Frankenhauser-Mannuß, J., Mueller, J., Lump, D., Boehm, B. O., & Rothenbacher, D. (2015) · BMC Public Health · doi:10.1186/s12889-015-2188-1 · Cited by 62
Schwingshackl, L., & HOFFMANN, G. E. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000464 · Cited by 61
Methods of accelerated atherosclerosis in diabetic patients
Pasterkamp, G. (2013) · Heart · doi:10.1136/heartjnl-2011-301172 · Cited by 60
Postchallenge Hyperglycemia Is Positively Associated With Diabetic Polyneuropathy
Bongaerts, B. W. C., Rathmann, W., Kowall, B., Herder, C., Stöckl, D., Meisinger, C., & Ziegler, D. (2012) · Diabetes Care · doi:10.2337/dc11-2028 · Cited by 60
Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy
Zou, H., Wang, Y., Gang, Q., Zhang, Y., & Sun, Y. (2017) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-017-3638-5 · Cited by 60
Christensen, D. H., Nicolaisen, S. K., Berencsi, K., Beck‐Nielsen, H., Rungby, J., Friborg, S. G., Brandslund, I., Christiansen, J. S., Vaag, A. A., Sørensen, H. T., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-017273 · Cited by 60
GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
Mori, Y., Matsui, T., Hirano, T., & Yamagishi, S.-I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041509 · Cited by 60
Attner, B., Landin‐Olsson, M., Lithman, T., Noreen, D., & Olsson, H. L. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9946-5 · Cited by 59
Bouchi, R., Fukuda, T., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2957 · Cited by 62
Mutyambizi, C., Pavlova, M., Hongoro, C., & Groot, W. N. J. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0492-y · Cited by 69
Ranjit Unnikrishnan, I., Shaw, J. E., Chan, J. C. N., Wild, S. H., Peters, A. L., Orrange, S., Roden, M., & Mohan, V. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00635-0 · Cited by 69
Diabetes and pancreatic cancer survival: a prospective cohort-based study
Toriola, A. T., Stolzenberg‐Solomon, R. Z., Dalidowitz, L., Linehan, D. C., & Colditz, G. A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.224 · Cited by 60
Cosmo, S. D., Copetti, M., Lamacchia, O., Fontana, A., Massa, M., Morini, E., Pacilli, A., Fariello, S., Palena, A. P., Rauseo, A., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1906 · Cited by 60
The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
Ofstad, A. P., Atar, D., Gullestad, L. L., Langslet, G., & Johansen, O. E. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9685-0 · Cited by 59
Reducing global diabetes burden by implementing solutions and identifying gaps: a Lancet Commission
Chan, J. C. N., Gregg, E. W., Sargent, J., & Horton, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30165-9 · Cited by 62
Menini, S., Iacobini, C., de Latouliere, L., Manni, I., Ionta, V., Fantauzzi, C. B., Pesce, C. M., Cappello, P., Novelli, F., Piaggio, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5072 · Cited by 58
Björkström, K., Stal, P. I., Hultcrantz, R. W., & Hagström, H. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.04.040 · Cited by 59
Trends in cancer mortality among people with vs without diabetes in the USA, 1988–2015
Harding, J. L., Andes, L. J., Gregg, E. W., Cheng, Y. J., Weir, H. K., Bullard, K. M., Burrows, N. R., & Imperatore, G. (2019) · Diabetologia · doi:10.1007/s00125-019-04991-x · Cited by 60
Longato, E., Camillo, B. D., Sparacino, G., Tramontan, L., Avogaro, A., & Fadini, G. P. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01049-w · Cited by 58
Sodium and Cardiovascular Disease
Saulnier, P., Gand, E., & Hadjadj, S. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1412113 · Cited by 60
Öztürk, D., Çelik, Ö., Satılmış, S., Aslan, S., Ertürk, M., Çakmak, H. A., Kalkan, A. K., Özyılmaz, S., Diker, V. Ö., & Gül, M. (2015) · Coronary Artery Disease · doi:10.1097/mca.0000000000000252 · Cited by 57
Rathmann, W., Scheidt‐Nave, C., Roden, M., & Herder, C. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0331 · Cited by 59
Zelenko, Z., & Gallagher, E. J. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.008 · Cited by 57
Vavallo, A., Simone, S., Lucarelli, G. T., Rutigliano, M., Galleggiante, V., Grandaliano, G., Gesualdo, L., Campagna, M., Cariello, M., Ranieri, E., et al. (2014) · Medicine · doi:10.1097/md.0000000000000183 · Cited by 57
Edwards, J. J., Griffiths, M., Deenmamode, A. H. P., & O’Driscoll, J. M. (2023) · Sports Medicine · doi:10.1007/s40279-023-01863-8 · Cited by 62
Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells
Ninomiya, I., Yamazaki, K., Oyama, K., Hayashi, H., Tajima, H., Kitagawa, H., Fushida, S., Fujimura, T., & Ohta, T. (2014) · Oncology Letters · doi:10.3892/ol.2014.2553 · Cited by 56
Pan, J., Chen, C., Jin, Y., Fuentes‐Mattei, E., Velázquez-Torres, G., Benito, J. M., Konopleva, M. Y., Andreeff, M., Lee, M., & Yeung, S. J. (2012) · Cell Cycle · doi:10.4161/cc.20770 · Cited by 56
Dysglycaemia, vasculopenia, and the chronic consequences of diabetes
Gerstein, H. C., & Werstuck, G. H. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70025-1 · Cited by 58
Anderson, S. G., Shoo, H., Saluja, S., Anderson, C. D., Khan, A., Livingston, M. A., Jude, E. B., Lunt, M., Dunn, G., & Heald, A. H. (2017) · Diabetologia · doi:10.1007/s00125-017-4522-x · Cited by 56
McCoy, R. G., Van Houten, H. K., Karaca-Mandic, P., Ross, J. S., Montori, V. M., & Shah, N. D. (2021) · Diabetes Care · doi:10.2337/dc20-2977 · Cited by 57
Spiazzi, B. F., Naibo, R. A., Wayerbacher, L. F., Piccoli, G. F., Farenzena, L. P., Londero, T. M., da Natividade, G. R., Zoldan, M., Degobi, N. A. H., Niches, M. D. S., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110621 · Cited by 59
Donohue, J. F., Elborn, J. S., Lansberg, P. J., Javed, A., Tesfaye, S. H., Rugo, H. S., Devi, R., Jithoo, N., Huang, P.-H., Subramaniam, K., et al. (2023) · Journal of Healthcare Leadership · doi:10.2147/jhl.s394088 · Cited by 56
Gu, Y., Wang, C., Zheng, Y., Hou, X., Mo, Y., Yu, W., Zhang, L., Hu, C., Nan, H., Chen, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053411 · Cited by 55
Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study
Simonsen, J. R., Harjutsalo, V., Järvinen, A., Kirveskari, J., Forsblom, C. M., Groop, P., & Lehto, M. J. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000067 · Cited by 55
Body Mass Index Trajectories among Middle-Aged and Elderly Canadians and Associated Health Outcomes
Wang, M., Yi, Y., Roebothan, B., Colbourne, J., Maddalena, V., Wang, P., & Sun, G. (2016) · Journal of Environmental and Public Health · doi:10.1155/2016/7014857 · Cited by 55
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials
Erpeldinger, S., Rehman, M. B., Berkhout, C., Pigache, C., Zerbib, Y., Regnault, F., Guérin, É., Supper, I., Cornu, C., Kassaï, B., et al. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0120-z · Cited by 60
Associations Between Cellular Aging Markers and Metabolic Syndrome: Findings From the CARDIA Study
Révész, D., Verhoeven, J. E., Picard, M. A., Lin, J., Sidney, S., Epel, E. S., Penninx, B. W. J. H., & Puterman, E. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01625 · Cited by 55
Statin diabetogenicity: guidance for clinicians
Ray, K. K. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-s1-s3 · Cited by 55
Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials
Bailey, C. J., & Marx, N. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13492 · Cited by 56
Randrianarisoa, E., Lehn‐Stefan, A., Hieronimus, A., Wagner, R. J., Maucher, J., Rittig, K., Balletshofer, B. M., Birkenfeld, A. L., Peter, A., Stefan, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-80581-x · Cited by 56
Bellanti, F., Buglio, A. L., Dobrakowski, M., Kasperczyk, A., Kasperczyk, S., Aich, P., Singh, S. P., Serviddio, G., & Vendemiale, G. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i26.3243 · Cited by 54
Validity of Diabetes Self-Reports in the Saku Diabetes Study
Goto, A., Morita, A., Goto, M., Sasaki, S., Miyachi, M., Aiba, N., Kato, M., Terauchi, Y., Noda, M., & Watanabe, S. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120221 · Cited by 53
Fadini, G. P., & Avogaro, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/742976 · Cited by 53
The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern
Currie, C. J., & Johnson, J. A. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01469.x · Cited by 54
Causes of death among diabetic patients in Denmark
Hansen, M. B., Jensen, M. L., & Carstensen, B. (2011) · Diabetologia · doi:10.1007/s00125-011-2383-2 · Cited by 53
Cardiovascular Risk Stratification and Management in Pre-Diabetes
Færch, K., Vistisen, D., Johansen, N. B., & Jørgensen, M. E. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0493-1 · Cited by 60
HbA1c and all-cause mortality risk among patients with type 2 diabetes
Li, W., Katzmarzyk, P. T., Horswell, R. L., Wang, Y., Johnson, J. L., & Hu, G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.070 · Cited by 54
Velho, G., Ragot, S., Boustany, R. E., Saulnier, P., Fraty, M., Mohammedi, K., Fumeron, F., Potier, L., Marre, M., Hadjadj, S., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0753-5 · Cited by 54
Exploiting metabolic vulnerabilities of Non small cell lung carcinoma
Majem, B., Nadal, E., & Muñoz‐Pinedo, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.06.004 · Cited by 57
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction
Schmitt, V. H., Hobohm, L., Münzel, T. F., Wenzel, P., Gori, T., & Keller, K. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.003 · Cited by 59
Vallarino, C. R., Perez, A., Fusco, G., Liang, H., Bron, M., Manne, S., Joseph, G. L., & Yu, S. S. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0106-9 · Cited by 53
Diabetes Risk Reduction Diet and Survival after Breast Cancer Diagnosis
Wang, T., Farvid, M. S., Kang, J. H., Holmes, M. D., ROSNER, B. A., Tamimi, R. M., Willett, W. C., & Eliassen, A. H. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0256 · Cited by 53
Benefits of timely basal insulin control in patients with type 2 diabetes
Lovre, D., & Fonseca, V. A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.018 · Cited by 55
de Lorgeril, M., Salen, P., Defaye, P., & Rabaeus, M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-5 · Cited by 53
Simpson, S. H., Lier, D. A., Majumdar, S. R., Tsuyuki, R. T., Lewanczuk, R. Z., Spooner, R., & Johnson, J. A. (2015) · Diabetic Medicine · doi:10.1111/dme.12692 · Cited by 54
Diabetes mellitus carries a risk of gastric cancer: A meta-analysis
Shimoyama, S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6902 · Cited by 53
The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease
Griffin, T. P., Martin, W. P., Islam, M. N., O’Brien, T., & Griffin, M. D. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0734-6 · Cited by 53
Shi, J., Xiong, L., Li, J., Cao, H., Jiang, W., Liu, B., Chen, X., Liu, C., Liu, K., Wang, G., et al. (2015) · Scientific Reports · doi:10.1038/srep17591 · Cited by 53
Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia
Sutherland, G. T., Lim, J., Srikanth, V. K., & Bruce, D. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161194 · Cited by 58
A first attempt to develop a diabetes prediction method based on different global datasets
Negi, A., & Jaiswal, V. (2016) · International Conference on Parallel, Distributed and Grid Computing (PDGC) · doi:10.1109/pdgc.2016.7913152 · Cited by 54
Glucose alters the symbiotic relationships between gut microbiota and host physiology
Anhê, F. F., Barra, N. G., & Schertzer, J. D. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00485.2019 · Cited by 53
Xin, Y., Davies, A., Briggs, A., McCombie, L., Messow, C. M., Grieve, E., Leslie, W. S., Taylor, R., & Lean, M. E. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05224-2 · Cited by 52
Gamble, J.-M., Chibrikov, E., Midodzi, W. K., Twells, L. K., & Majumdar, S. R. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023830 · Cited by 52
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters
Alahmad, B., Al‐Shammari, A. A., Bennakhi, A., Al‐Mulla, F., & Ali, H. (2020) · Diabetes Care · doi:10.2337/dc20-1941 · Cited by 52
Raguraman, R., Srivastava, A., Munshi, A., & Ramesh, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113918 · Cited by 54
Kianmehr, H., Zhang, P., Luo, J., Guo, J. S., Pavkov, M. E., Bullard, K. M., Gregg, E. W., Ospina, N. S., Fonseca, V. A., Shi, L., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.7705 · Cited by 55
Shafagh, R. Z., Youhanna, S. C., Keulen, J., Shen, J. X., Taebnia, N., Preiss, L. C., Klein, K., Büttner, F., Bergqvist, M., van der Wijngaart, W., et al. (2022) · Advanced Science · doi:10.1002/advs.202203368 · Cited by 55
Bello‐Chavolla, O. Y., Antonio‐Villa, N. E., Fermín‐Martínez, C. A., Fernández‐Chirino, L., Vargas‐Vázquez, A., Ramírez‐García, D., Basile‐Alvarez, M. R., Hoyos-Lázaro, A. E., Carrillo-Larco, R. M., Wexler, D. J., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0616 · Cited by 52
Epner, M., Yang, P., Wagner, R. W., & Cohen, L. G. (2022) · Cancers · doi:10.3390/cancers14246042 · Cited by 56
Ling, S., Zaccardi, F., Issa, E., Davies, M. J., Khunti, K., & Brown, K. (2023) · Diabetologia · doi:10.1007/s00125-022-05854-8 · Cited by 53
Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
Fadini, G. P., Fiala, M. A., Cappellari, R., D’Anna, M., Park, S., Poncina, N., Menegazzo, L., Albiero, M., DiPersio, J. F., Stockerl-Goldstein, K. E., et al. (2015) · Diabetes · doi:10.2337/db15-0077 · Cited by 52
Metadata
- Authors
- The Emerging Risk Factors Collaboration
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- The Emerging Risk Factors Collaboration
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-03-03
- Volume
- 364
- Issue
- 9
- Pages
- 829-841
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4109980
- OpenAlex
- W2126919962
- Semantic Scholar
- a89247dcde559e5839cef19b130059e2ad9abc75
- Cited by
- 2,726
- References
- 40
- Citations by year
- 2026: 102 · 2025: 138 · 2024: 186 · 2023: 151 · 2022: 200 · 2021: 225 · 2020: 218 · 2019: 182 · 2018: 190 · 2017: 203 · 2016: 190 · 2015: 196 · 2014: 193 · 2013: 145 · 2012: 147
- FWCI
- 141.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/013/25942, RG/08/014, PG/09/002/26056, RG/07/008/23674, RG/08/014/24067)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc085083-027, n01hc085080-026, n01hc085086-022, UL1TR000062, n01hc55222-0-0-0)
- Economic and Social Research Council (ES/G007438/1)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (N01 HC085086, N01 HC085079, N01 HC085083, N01 HC085080, HHSN 268200800007C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081)
- National Center for Research Resources (UL1RR025014)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, fasting blood glucose, hyperglycemia, cause-specific mortality, cancer mortality, vascular death, premature mortality, liver cancer, pancreatic cancer, ovarian cancer, colorectal cancer, lung cancer, breast cancer, renal disease mortality, infectious disease mortality, intentional self-harm, chronic obstructive pulmonary disease, mortality risk factors
- MeSH terms
- Blood Glucose, Cause of Death, Diabetes Mellitus, Female, Humans, Hyperglycemia, Life Expectancy, Male, Middle Aged, Risk, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
